A recent study has shown that, in liver-specific ChREBP knockout mice, fatty liver and glucose intolerance were improved, while liver-specific SREBP-1c and PPAR-γ knockout mice could only improve fatty liver. The gene discussed is SREBF1; the disease is Glucose intolerance.